Status:
WITHDRAWN
Blood Flow Changes in Femoral-popliteal Bypass Grafts After Neuromuscular Electrical Stimulation (NMES).
Lead Sponsor:
Imperial College Healthcare NHS Trust
Conditions:
Peripheral Arterial Disease
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The muscles of the leg require a regular supply of oxygen and nutrients. This is supplied by blood carried by a network of large blood vessels known as arteries. Gradually, these arteries can become n...
Detailed Description
Within the vascular department at Charing Cross Hospital, there is an on-going NIHR-funded trial looking at the haemodynamics and clinical outcomes of patients with intermittent claudication. The aim ...
Eligibility Criteria
Inclusion
- Have a confirmed diagnosis of peripheral arterial disease (PAD);
- Have undergone revascularisation surgery via a vein femoral-popliteal bypass graft;
- Are willing to participate and are able to provide written informed consent;
- Are aged over 18 years;
- Agree to attend at least one of their usual clinic appointments at the Vascular Outpatients department at Charing Cross Hospital, London before 13th April 2020 (project deadline for the student is Monday 11th May 2020);
- Have a body mass index (BMI) between 17 and 30 kg/m2.
Exclusion
- Do not have a diagnosis of PAD;
- Have not had revascularisation surgery;
- Have had revascularisation surgery via an artificial femoral-popliteal bypass graft;
- Are fitted with an electronic implanted device;
- Are being treated for (or have symptoms of) a deep vein thrombosis (DVT);
- Are pregnant.
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04109287
Start Date
February 11 2020
End Date
October 5 2022
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charing Cross Hospital
London, United Kingdom, W6 8RF